Literature DB >> 23010889

Autoimmune manifestations in viral hepatitis.

Diego Vergani1, Giorgina Mieli-Vergani.   

Abstract

Infections by the viruses responsible for hepatitis B, C and D are accompanied by a number of immunopathological manifestations. A link between infection and autoimmunity is particularly well documented for the hepatitis C virus. Immunopathological manifestations range from production of autoantibodies to overt autoimmune disease, including thyroiditis and autoimmune hepatitis, and to immune-complex-mediated disorders, including cryoglobulinaemia, glomerulonephritis and vasculitis. Several of these manifestations improve with successful antiviral treatment, directly incriminating the virus in their pathogenesis. Mechanisms considered responsible for hepatitis virus-related immunopathology, including molecular mimicry, impairment of regulatory T cells and activation of B lymphocytes, will be examined in this review.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23010889     DOI: 10.1007/s00281-012-0328-6

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   11.759


  141 in total

Review 1.  Immunopathology or organ-specific autoimmunity as a consequence of virus infection.

Authors:  P Aichele; M F Bachmann; H Hengartner; R M Zinkernagel
Journal:  Immunol Rev       Date:  1996-08       Impact factor: 12.988

2.  Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients.

Authors:  V Racanelli; D Sansonno; C Piccoli; F P D'Amore; F A Tucci; F Dammacco
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

Review 3.  Gastrointestinal and hepatic manifestations of Sjogren syndrome.

Authors:  Ellen Catherine Ebert
Journal:  J Clin Gastroenterol       Date:  2012-01       Impact factor: 3.062

4.  Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseases.

Authors:  T Bachrich; T Thalhammer; W Jäger; P Haslmayer; B Alihodzic; S Bakos; E Hitchman; A M Senderowicz; E Penner
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

5.  Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis.

Authors:  C P Strassburg; P Obermayer-Straub; B Alex; M Durazzo; M Rizzetto; R H Tukey; M P Manns
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

6.  PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

Authors:  Patrice Cacoub; David Saadoun; Nicolas Limal; Damien Sene; Olivier Lidove; Jean-Charles Piette
Journal:  Arthritis Rheum       Date:  2005-03

Review 7.  Immunologic features and HLA associations in chronic viral hepatitis.

Authors:  A J Czaja; H A Carpenter; P J Santrach; S B Moore
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

8.  A role for hepatitis C virus infection in type II cryoglobulinemia.

Authors:  V Agnello; R T Chung; L M Kaplan
Journal:  N Engl J Med       Date:  1992-11-19       Impact factor: 91.245

9.  Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: a multicentric study of 596 cases. The Italian Group for the Study of Cryoglobulinemias (GISC).

Authors:  M Galli; G Monti; F Invernizzi; A Monteverde; S Bombardieri; A Gabrielli; S Migliaresi; C Mussini; E Ossi; M Pietrogrande
Journal:  Ann Ital Med Int       Date:  1992 Oct-Dec

10.  Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment.

Authors:  Paolo Muratori; Luigi Muratori; Gabriella Verucchi; Luciano Attard; Francesco B Bianchi; Marco Lenzi
Journal:  Clin Infect Dis       Date:  2003-10-13       Impact factor: 9.079

View more
  21 in total

Review 1.  Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy.

Authors:  Gerson Dierley Keppeke; S John Calise; Edward K L Chan; Luis Eduardo C Andrade
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 2.  Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders.

Authors:  Deng-Ho Yang; Ling-Jun Ho; Jenn-Haung Lai
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 3.  Role of viruses and bacteria-virus interactions in autoimmunity.

Authors:  Ashley L Steed; Thaddeus S Stappenbeck
Journal:  Curr Opin Immunol       Date:  2014-10-27       Impact factor: 7.486

Review 4.  Immunomodulatory effects of transforming growth factor-β in the liver.

Authors:  Hans-Theo Schon; Ralf Weiskirchen
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

Review 5.  Pathogens and autoimmune hepatitis.

Authors:  U Christen; E Hintermann
Journal:  Clin Exp Immunol       Date:  2018-10-07       Impact factor: 4.330

6.  Normal vitamin D levels are associated with spontaneous hepatitis B surface antigen seroclearance.

Authors:  Mahmud Mahamid; William Nseir; Omar Abu Elhija; Shimon Shteingart; Ammad Mahamid; Mosab Smamra; Benjamin Koslowsky
Journal:  World J Hepatol       Date:  2013-06-27

7.  Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.

Authors:  Gerson Dierley Keppeke; Minoru Satoh; Maria Lucia Gomes Ferraz; Edward K L Chan; Luís Eduardo C Andrade
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

Review 8.  Complexities in the relationship between infection and autoimmunity.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

Review 9.  Environmental peer pressure: CD4+ T cell help in tolerance and transplantation.

Authors:  Dana Tedesco; Arash Grakoui
Journal:  Liver Transpl       Date:  2018-01       Impact factor: 5.799

10.  Is there an association between pemphigus and hepatitis viruses? A population-based large-scale study.

Authors:  Khalaf Kridin; Shira Zelber-Sagi; Doron Comaneshter; Arnon D Cohen
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.